default author photo

Caroline Laprie

Laboratoire Vet-Histo

SCHOLARLY PAPERS

2

DOWNLOADS

129

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Further Preclinical Characterization of Molnupiravir Against SARS-CoV-2: Antiviral Activity Determinants and Viral Genome Alteration Patterns

Number of pages: 32 Posted: 03 Mar 2024
Aix-Marseille University, Aix Marseille Université - Emerging Viruses Unit, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Laboratoire Vet-Histo, Aix-Marseille University, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Aix Marseille Université - Emerging Viruses Unit, Aix-Marseille University and Aix Marseille Université - Emerging Viruses Unit
Downloads 82 (816,709)
Citation 1

Abstract:

Loading...

COVID-19, antiviral drug, nucleoside analog, mutagenesis, animal model, HAE

2.

Preclinical Evaluation in Hamster Model of the Mrna Covid-19 Vaccine Candidate Afrivac 2121 (Wuhan) Produced Under the Who/Mpp Mrna Technology Transfer Programme

Number of pages: 24 Posted: 15 Jul 2024
Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Laboratoire Vet-Histo, Afrigen Biologics (Pty) Ltd., affiliation not provided to SSRN, affiliation not provided to SSRN, Aix Marseille Université - Emerging Viruses Unit and Aix Marseille Université - Emerging Viruses Unit
Downloads 47 (1,109,210)

Abstract:

Loading...

SARS-CoV-2, COVID-19, mRNA vaccine, hamster model